NSEGeneral Updates2d ago · 19 Jul 2026, 06:21 pm
General Updates
Medplus Health Services Limited · MEDPLUS
✦ AI Summary▼ NegativeRegulatory
MedPlus Health Services Limited has received a suspension order for a Drug License of a store situated in Karnataka due to a two-day suspension under Rule 65 of the Drugs and Cosmetics Act, 1940, resulting in a potential revenue loss of Rs 0.53 lacs.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment2/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
MEDPLUS_19072026181851_Intimation.pdf
View document text
MedPlus Health Services Limited
July 19, 2026
The Listing Department The Listing Department
BSE Limited N ational Stock Exchange of India Limited
Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor
Dalal Street, Fort, Plot No. C/1, G Block,
Mumbai – 400001 Bandra - Kurla Complex
BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051
NSE Symbol: MEDPLUS
Dear Sir/Madam,
Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has
received one suspension order for a Drug License of a store situated in the state of Karnataka:
Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD
POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows:
Name(s) of the Nature and details of Date of receipt Details of the Impact on
Authority the action(s) taken, of direction or violation(s)/ financial
initiated or order(s) order, including contravention(s) operation or
passed any interim or committed or other activities
interim orders, alleged to be of the listed
or any other committed entity,
communication quantifiable in
from the monetary terms
authority to the extent
possible
Assistant Director, Suspension of Drug Order received Under Rule 65 of Potential
Drugs Control License for two days of on 18.07.2026 Drugs and Cosmetics Revenue Loss of
Administration, store situated at Indi Act, 1940 and Drugs Rs 0.53 lacs.
Vijayapura Circle, Sindagi Road Bijapur, and Cosmetics
Vijayapura, Karnataka. Karnataka. Rules, 1945
The same will be available on the website of the Company at www.medplusindia.com and also on the websites
of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com
respectively. Kindly take the same on records.
For MedPlus Health Services Limited
Gangadi Madhukar Reddy
Managing Director and Chief Executive Officer
040-6724 672
Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India
CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com